UCB today announced findings from new studies of the once-daily antiepileptic drug (AED) Keppra XR™ (levetiracetam) extended-release tablets comparing tolerability vs. levetiracetam immediate release ...
Levetiracetam 100mg/mL; grape flavor; dye-free. Swallow tabs whole. Partial onset: ≥16yrs: initially 500mg twice daily. May increase at 2-week intervals in increments of 1g/day; max 3g/day. Myoclonic: ...
Levetiracetam 100mg/mL; IV infusion after dilution. Infuse over 15mins. Partial onset: ≥16yrs: initially 500mg twice daily; may increase at 2-week intervals in increments of 1g/day; max 3g/day.
NEW YORK (Reuters Health) - Treatment with low doses of levetiracetam, the active ingredient in the drug Keppra, appears to be effective by itself for controlling newly diagnosed epilepsy, new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback